- Home
- MYFW vs INZY Comparison
MYFW vs INZY Comparison
Compare MYFW & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- INZY
- Stock Information
- Founded
- MYFW 2002
- INZY 2015
- Country
- MYFW United States
- INZY United States
- Employees
- MYFW N/A
- INZY N/A
- Industry
- MYFW Major Banks
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- INZY Health Care
- Exchange
- MYFW Nasdaq
- INZY Nasdaq
- Market Cap
- MYFW 184.7M
- INZY 188.2M
- IPO Year
- MYFW 2018
- INZY 2020
- Fundamental
- Price
- MYFW $17.70
- INZY $1.54
- Analyst Decision
- MYFW Buy
- INZY Strong Buy
- Analyst Count
- MYFW 3
- INZY 8
- Target Price
- MYFW $22.33
- INZY $17.75
- AVG Volume (30 Days)
- MYFW 19.0K
- INZY 666.9K
- Earning Date
- MYFW 01-23-2025
- INZY 11-05-2024
- Dividend Yield
- MYFW N/A
- INZY N/A
- EPS Growth
- MYFW N/A
- INZY N/A
- EPS
- MYFW 0.26
- INZY N/A
- Revenue
- MYFW $79,649,000.00
- INZY N/A
- Revenue This Year
- MYFW N/A
- INZY N/A
- Revenue Next Year
- MYFW $12.86
- INZY N/A
- P/E Ratio
- MYFW $67.42
- INZY N/A
- Revenue Growth
- MYFW N/A
- INZY N/A
- 52 Week Low
- MYFW $12.84
- INZY $1.62
- 52 Week High
- MYFW $22.32
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- MYFW 26.36
- INZY 22.68
- Support Level
- MYFW $17.10
- INZY $2.68
- Resistance Level
- MYFW $19.41
- INZY $3.18
- Average True Range (ATR)
- MYFW 0.64
- INZY 0.27
- MACD
- MYFW -0.18
- INZY -0.11
- Stochastic Oscillator
- MYFW 18.37
- INZY 1.87
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.